Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe

Vaccine

Volumn 31, Issue S7, 2013, Pages

  Poljak, Mario ^a   Seme, Katja ^a   Maver, Polona J ^a   Kocjan, Boštjan J ^a   Cuschieri, Kate S ^b   Rogovskaya, Svetlana I ^c   Arbyn, Marc ^d,e   Syrjänen, Stina ^f  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c Russian Medical Academy of Postgraduate Education   (Russian Federation)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

Central Europe; Cervical cancer; Eastern Europe; HPV; HPV vaccination; Screening

Indexed keywords

WART VIRUS VACCINE;

ALBANIA; BOSNIA AND HERZEGOVINA; BULGARIA; CANCER IMMUNIZATION; CANCER SCREENING; CONDYLOMA ACUMINATUM; CROATIA; CZECH REPUBLIC; ESTONIA; HEALTH SURVEY; HIGH GRADE CERVICAL LESION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUNGARY; LARYNX PAPILLOMATOSIS; LATVIA; MACEDONIA (REPUBLIC); MONTENEGRO (REPUBLIC); PAPILLOMAVIRUS INFECTION; POLAND; PRIORITY JOURNAL; REVIEW; ROMANIA; SERBIA; SLOVAKIA; SLOVENIA; SPECIES DISTRIBUTION; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE;

CENTRAL EUROPE; CERVICAL CANCER; EASTERN EUROPE; HPV; HPV VACCINATION; SCREENING;

EARLY DETECTION OF CANCER; EUROPE, EASTERN; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84878054954     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.029     Document Type: Review

References (40)

1. Arbyn M., Castellsagué X., de Sanjosé S., Bruni L., Saraiya M., Bray F., Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22:2675-2686.
2. Bray F., Lortet-Tieulent J., Znaor A., Brotons M., Poljak M., Arbyn M. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H32-H45.
3. Rogovskaya S.I., Shabalova I.P., Mikheeva I.V., Minkina G.N., Podzolkova N.M., Shipulina O.Y., et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus region and Central Asia. Vaccine 2013, 31S:H46-H58.
4. Učakar V., Poljak M., Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study. Vaccine 2012, 30:116-120.
5. Bruni L., Diaz M., Castellsagué X., Ferrer E., Bosch F.X., de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202:1789-1799.
6. Tachezy R., Smahelova J., Salakova M., Arbyn M., Rob L., Skapa P., et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One 2011, 6:e21913.
7. Kovanda A., Juvan U., Šterbenc A., Kocjan B.J., Seme K., Jančar N., et al. Pre-vaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia. Acta Dermatovenerol Alp Panonica Adriat 2009, 18:47-52.
8. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl 10):K1-K16.
9. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjosé S., Franceschi S., et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131:2349-2359.
10. Nowakowski A, de Sanjose S, Alemany L, Klaustermeier JE, Lloveras B, Kotarski J, et al. HPV prevalence and genotype distribution in cervical cancer in Poland. In: Abstract Book of the 27th International Papillomavirus Conference and Clinical Workshop. Berlin, Germany, 2011:p.52.
11. Jančar N., Kocjan B.J., Poljak M., Lunar M.M., Bokal E.V. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. Eur J Obstet Gynecol Reprod Biol 2009, 145:184-188.
12. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2010, 128:927-935.
13. de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., et al. Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048-1056.
14. Grce M., Husnjak K., Skerlev M., Lipozenčić J., Pavelić K. Detection and typing of human papillomaviruses by means of polymerase chain reaction and fragment length polymorphism in male genital lesions. Anticancer Res 2000, 20(3B):2097-2102.
15. Skerlev M., Grce M., Sirotkoviae-Skerlev M., Husnjak K., Lipozenčić J. Human papillomavirus male genital infections: clinical variations and the significance of DNA typing. Clin Dermatol 2002, 20:173-178.
16. Potočnik M., Kocjan B.J., Seme K., Poljak M. Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia. Acta Dermatovenerol Alp Panonica Adriat 2007, 16:91-98.
17. Komloš K.F., Kocjan B.J., Košorok P., Luzar B., Meglič L., Potočnik M., et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol 2012, 84(8):1233-1241.
18. Velyvyte D., Laiskonis A., Uloza V., Gozdzicka-Jozefiak A. Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina (Kaunas) 2002, 38:499-504.
19. Ferluga D., Luzar B., Vodovnik A., Poljak M., Cör A., Gale N., et al. Langerhans cells in human papillomaviruses types 6/11 associated laryngeal papillomas. Acta Otolaryngol Suppl 1997, 527:87-91.
20. Gale N. Papilloma/papillomatosis. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press, 2005: p 144-5.
21. Pajtler M., Audy-Jurković S., Kardum-Skelin I., Mahovlić V., Mozetić-Vrdoljak D., Ovanin-Rakić A. Organisation of cervical cytology screening in Croatia: past, present and future. Coll Antropol 2007, 31(Suppl 2):47-54.
22. Syrjänen K., Di Bonito L., Gonçalves L., Murjal L., Santamaria M., Mahovlić V., et al. Cervical cancer screening in Mediterranean countries: implications for the future. Cytopathology 2010, 21:359-367.
23. Nicula F.A., Anttila A., Neamtiu L., Žakelj M.P., Tachezy R., Chil A., et al. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer 2009, 45:2679-2684.
24. Kesić V., Jovićević-Bekić A., Vujnović M. Cervical cancer screening in Serbia. Coll Antropol 2007, 31(Suppl 2):31-36.
25. Hakama M., Chamberlain J., Day N.E., Miller A.B., Prorok P.C. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 1985, 52:669-673.
26. Arbyn M., Anttila A., Jordan J., Ronco G., Schenck U., Segnan N., et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition - summary document. Ann Oncol 2010, 21:448-458.
27. Primic-Žakelj M., Repše-Fokter A. Cervical cancer screening: A Slovenian experience. Coll Antropol 2007, 31(Suppl 2):23-26.
28. Anttila A., Ronco G. Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009, 45:2685-2708.
29. Arbyn M., Rebolj M., De Kok I.M., Fender M., Becker N., O'Reilly M., et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009, 45:2671-2678.
30. Zadnik V, Primic Žakelj M. SLORA: Slovenia and Cancer. Epidemiology and Cancer Registry. Institute of Oncology Ljubljana. (last accessed April 2012). http://www.slora.si/.
31. Viberga I., Engele L., Baili P. EUROCHIP Working Group. Past, present and future of the cervical cancer screening in Latvia. Tumori 2010, 96:529-537.
32. Veerus P., Arbyn M., Amati C., Paolo B. EUROCHIP Working Group. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia. Tumori 2010, 96:524-528.
33. Apostol I., Baban A., Nicula F., Suteu O., Coza D., Amati C., et al. EUROCHIP Working Group. Cervical cancer assessment in Romania under EUROCHIP-2. Tumori 2010, 96:545-552.
34. Valerianova Z., Panayotova Y., Amati C., Baili P. EUROCHIP Working Group. Cervical cancer screening in Bulgaria-past and present experience. Tumori 2010, 96:538-544.
35. Morris L, Herold J, Bino S, Yili A, Jackson D. Reproductive Health Survey Albania 2002. Final Report. Atlanta, GA, USA: Division of Reproductive Health, Centers for Disease Control and Prevention (DRH/CDC); May 2005.
36. Prymula R., Anca I., André F., Bakir M., Czajka H., Lutsar I., et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines. Eur J Pediatr 2009, 168:1031-1035.
37. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. on behalf of the VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE 2 2010 survey. Euro Surveill 2010;15:pii=19730.
38. Obradović M., Mrhar A., Kos M. Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia. Eur J Public Health 2010, 20:415-421.
39. Mareka E., Dergezc T., Rebek-Nagyd G., Kricskovicse A., Kovacsf K., Bozsag S., et al. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011, 29:8591-8598.
40. Poljak M., Rogovskaya S.I., Kesić V., Bray F., Berkhof J., Seme K., et al. Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H80-H82.